Positive Data from BLU-808 Healthy Volunteer Trial Blueprint today announced results from the Phase 1 single-ascending dose (SAD; n=56) and multiple-ascending dose (MAD; n=31, 14-day dosing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback